JP2013520488A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013520488A5 JP2013520488A5 JP2012554446A JP2012554446A JP2013520488A5 JP 2013520488 A5 JP2013520488 A5 JP 2013520488A5 JP 2012554446 A JP2012554446 A JP 2012554446A JP 2012554446 A JP2012554446 A JP 2012554446A JP 2013520488 A5 JP2013520488 A5 JP 2013520488A5
- Authority
- JP
- Japan
- Prior art keywords
- perphenazine
- crystalline form
- showing
- aminobutyrate
- xrpd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30748110P | 2010-02-24 | 2010-02-24 | |
| US30748210P | 2010-02-24 | 2010-02-24 | |
| US61/307,482 | 2010-02-24 | ||
| US61/307,481 | 2010-02-24 | ||
| PCT/IB2011/000915 WO2011104637A2 (en) | 2010-02-24 | 2011-02-24 | Crystalline forms of the tri-mesylate salt of perphenazine-gaba and process of producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013520488A JP2013520488A (ja) | 2013-06-06 |
| JP2013520488A5 true JP2013520488A5 (enExample) | 2014-01-30 |
Family
ID=44507308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012554446A Pending JP2013520488A (ja) | 2010-02-24 | 2011-02-24 | ペルフェナジン−ｇａｂａのトリメシラート塩の結晶性形態物及びその製法方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8377929B2 (enExample) |
| EP (1) | EP2539857A4 (enExample) |
| JP (1) | JP2013520488A (enExample) |
| CN (1) | CN102858345A (enExample) |
| AU (1) | AU2011219529A1 (enExample) |
| CA (1) | CA2789654A1 (enExample) |
| IL (1) | IL221461A0 (enExample) |
| MX (1) | MX2012009821A (enExample) |
| WO (1) | WO2011104637A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7544681B2 (en) * | 2001-09-27 | 2009-06-09 | Ramot At Tel Aviv University Ltd. | Conjugated psychotropic drugs and uses thereof |
| JP5284779B2 (ja) * | 2005-06-07 | 2013-09-11 | ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド | コンジュゲート化された向精神薬の新規な塩およびその調製方法 |
| WO2008010223A2 (en) * | 2006-07-17 | 2008-01-24 | Ramot At Tel Aviv University Ltd. | Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use in treating pain and other cns disorders |
| US8207369B2 (en) * | 2008-02-11 | 2012-06-26 | Ramot At Tel-Aviv University Ltd. | Conjugates for treating neurodegenerative diseases and disorders |
| CN102762211A (zh) | 2009-12-09 | 2012-10-31 | 拜欧利纳斯有限公司 | 改善认知功能的方法 |
| MX2012009821A (es) | 2010-02-24 | 2012-10-09 | Univ Ramot | Formas cristalinas de la sal de tri-mesilato de perfenazina-gaba y proceso para producirlas. |
| US8916610B2 (en) | 2010-09-22 | 2014-12-23 | Ramot At Tel-Aviv University Ltd. | Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same |
| US10562930B1 (en) * | 2018-08-31 | 2020-02-18 | Praxis Precision Medicines, Inc. | Salts and crystal forms of GABAA positive allosteric modulator |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1460713A (en) | 1973-06-08 | 1977-01-06 | Kefalas As | 7-fluoro substituted phenothiazines method for preparation thereof and compositions bladed rotor for a gas turbine engine |
| US5525727A (en) | 1982-05-18 | 1996-06-11 | University Of Florida | Brain-specific drug delivery |
| GB8608335D0 (en) | 1986-04-04 | 1986-05-08 | Pfizer Ltd | Pharmaceutically acceptable salts |
| US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| US5780590A (en) | 1993-10-15 | 1998-07-14 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| US5534522A (en) | 1995-06-07 | 1996-07-09 | Warner-Lambert Company | (R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent |
| AU6636996A (en) | 1995-07-13 | 1997-02-10 | Anormed Inc. | 2-{2-(dimethylamino)ethyl}-8,8-dipropyl-2-azaspiro{4.5}decan edimaleate |
| DE19622489A1 (de) | 1996-06-05 | 1997-12-11 | Hoechst Ag | Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters |
| US6130221A (en) | 1997-03-05 | 2000-10-10 | Nymox Corporation | Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions |
| TWI238062B (en) | 1999-12-01 | 2005-08-21 | Ucb Sa | A pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders |
| JP2005097120A (ja) | 2000-10-06 | 2005-04-14 | Mochida Pharmaceut Co Ltd | ４−ヒドロキシピペリジン誘導体の非潮解性塩 |
| US7544681B2 (en) * | 2001-09-27 | 2009-06-09 | Ramot At Tel Aviv University Ltd. | Conjugated psychotropic drugs and uses thereof |
| KR100996239B1 (ko) | 2001-09-27 | 2010-11-23 | 바-일란 유니버시티 | 접합된 항-정신병 약물 및 그의 용도 |
| US7005138B2 (en) | 2001-12-21 | 2006-02-28 | Duramed Pharmaceuticals, Inc. | Method of systematically delivering SSRIs |
| US20040092504A1 (en) | 2002-11-12 | 2004-05-13 | Anuthep Benja-Athon | Definitive medications for treating fibromyalgia |
| TW200616604A (en) | 2004-08-26 | 2006-06-01 | Nicholas Piramal India Ltd | Nitric oxide releasing prodrugs containing bio-cleavable linker |
| CN101247837B (zh) * | 2005-06-07 | 2013-03-20 | 特拉维夫大学拉莫特有限公司 | 新的轭合精神活性药物的盐及其制备方法 |
| JP5284779B2 (ja) * | 2005-06-07 | 2013-09-11 | ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド | コンジュゲート化された向精神薬の新規な塩およびその調製方法 |
| TWI378091B (en) * | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
| US7872046B2 (en) * | 2008-01-25 | 2011-01-18 | Xenoport, Inc. | Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use |
| MX2012009821A (es) | 2010-02-24 | 2012-10-09 | Univ Ramot | Formas cristalinas de la sal de tri-mesilato de perfenazina-gaba y proceso para producirlas. |
| US8916610B2 (en) | 2010-09-22 | 2014-12-23 | Ramot At Tel-Aviv University Ltd. | Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same |
-
2011
- 2011-02-24 MX MX2012009821A patent/MX2012009821A/es not_active Application Discontinuation
- 2011-02-24 AU AU2011219529A patent/AU2011219529A1/en not_active Abandoned
- 2011-02-24 CN CN2011800207232A patent/CN102858345A/zh active Pending
- 2011-02-24 EP EP11746937.9A patent/EP2539857A4/en not_active Withdrawn
- 2011-02-24 US US13/034,453 patent/US8377929B2/en not_active Expired - Fee Related
- 2011-02-24 CA CA2789654A patent/CA2789654A1/en not_active Abandoned
- 2011-02-24 JP JP2012554446A patent/JP2013520488A/ja active Pending
- 2011-02-24 WO PCT/IB2011/000915 patent/WO2011104637A2/en not_active Ceased
-
2012
- 2012-08-14 IL IL221461A patent/IL221461A0/en unknown
-
2013
- 2013-02-11 US US13/763,815 patent/US20130150352A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013520488A5 (enExample) | ||
| JP2014524442A5 (enExample) | ||
| JP2007532560A5 (enExample) | ||
| JP2013049690A5 (enExample) | ||
| JP2017522276A5 (enExample) | ||
| JP2013543867A5 (enExample) | ||
| JP2010535742A5 (enExample) | ||
| JP2018024682A5 (enExample) | ||
| JP2019501865A5 (enExample) | ||
| CN1227233C (zh) | 纯晶形的5－氯－3－(4－甲磺酰基苯基)－6′－甲基－[2,3′]联吡啶及其合成方法 | |
| ES2613716T3 (es) | Formas cristalinas de un derivado de purina | |
| JP2013032389A5 (enExample) | ||
| JP2023002516A5 (enExample) | ||
| JP2015500331A5 (enExample) | ||
| FI3792254T3 (fi) | Kiteisiä metyylitioniniumkloridihydraatteja | |
| JP2009531465A5 (enExample) | ||
| RU2017142958A (ru) | Кристаллы азабициклического соединения | |
| JP2013514974A5 (enExample) | ||
| JP2013503134A5 (enExample) | ||
| JP2014510746A5 (enExample) | ||
| JP2014530818A5 (enExample) | ||
| JP2013501041A5 (enExample) | ||
| JP2015522037A5 (enExample) | ||
| JP2020502224A5 (enExample) | ||
| JP2016510767A5 (enExample) |